4//SEC Filing
Richards C Marc 4
Accession 0001209191-21-016905
CIK 0000893949other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:43 PM ET
Size
7.5 KB
Accession
0001209191-21-016905
Insider Transaction Report
Form 4
Richards C Marc
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2021-03-01+28,571→ 52,069 total - Award
Common Stock
2021-03-01+28,572→ 80,641 total
Footnotes (2)
- [F1]Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 14,286 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2021. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five (25%) on March 1, 2022, twenty-five (25%) on March 1, 2023 and fifty (50%) on March 1, 2024, subject to the terms of the Plan.
- [F2]Restricted shares granted pursuant to the Issuer's Plan, in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2022, twenty-five percent (25%) of the restricted shares will vest on March 1, 2023 and fifty percent (50%) of the restricted shares will vest on March 1, 2024.
Documents
Issuer
MEDNAX, INC.
CIK 0000893949
Entity typeother
Related Parties
1- filerCIK 0001468881
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:43 PM ET
- Size
- 7.5 KB